Track funded deeptech companies, founders and investors across the UK startup ecosystem.
| Date | Startup | Funding | Round | Sector | Location | Connect | Website | Investor1 | Investor2 | Investor3 | Investor4 | Investor5 | Founder(s) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17 Nov 2026 | Isomorphic Labs IsoDDE is a unified drug design engine that uses AI and simulation models t... | £3,800,000,000 | |||||||||||
16 Nov 2026 | TileBio TileBio provides a machine learning model trained on unlabelled histology i... | £2,261,000 | |||||||||||
16 Nov 2026 | Zya Convero is a dry powdered enzyme ingredient formulated for inclusion in low... | £11,350,000 US$15,000,000 | |||||||||||
12 Nov 2026 | Fractile Fractile builds rack-scale inference accelerators that stack DRAM and combi... | £540,000,000 | |||||||||||
11 Nov 2026 | Tendrils A processor and a companion language called Vine designed to run many tasks... | £22,430,000 US$30,000,000 | |||||||||||
10 Nov 2026 | Neobe Neobe develops engineered bacteria that colonise tumours and release enzyme... | £5,060,000 US$6,800,000 | |||||||||||
10 Nov 2026 | Oyster Therapeutics Oyster Therapeutics develops an oral tau degrader using its SELFTAC platfor... | £44,680,000 US$60,000,000 | |||||||||||
9 Nov 2026 | PhaSER Biomedical PhaSER Biomedical offers the 8HUM humanised mouse platform and supporting c... | £2,000,000 | |||||||||||
6 Nov 2026 | bio.bit bio.bit supplies human cell models and an opti-ox platform that programs ce... | £18,570,000 US$25,000,000 | |||||||||||
5 Nov 2026 | FluoRok A manufacturing platform that produces fluorochemicals without hydrogen flu... | £22,270,000 US$30,000,000 | |||||||||||
5 Nov 2026 | T-Therapeutics T-Therapeutics develops therapies that use a platform to supply fully human... | £100,000,000 | |||||||||||
5 Nov 2026 | Alethio Therapeutics ATX-011 is a monoclonal antibody that binds a disease-associated cell surfa... | £67,000,000 | |||||||||||
5 Nov 2026 | Potential Sciences Potential Sciences offers a software platform that generates large-scale qu... | ||||||||||||
3 Nov 2026 | Bioliberty Lifeglov is a soft-robotic glove paired with AI that supports physical reha... | £7,700,000 | |||||||||||
3 Nov 2026 | OSSTEC ASCENT is a cementless partial knee implant made using 3D-printed component... | £5,970,000 US$8,000,000 | |||||||||||
3 Nov 2026 | Viridi Vireya is an anionic surfactant made from captured carbon dioxide using Vir... | £2,200,000 | |||||||||||
26 Oct 2026 | imphatec A small implant placed under the skin that steadily releases medication ove... | £1,500,000 | |||||||||||
16 Oct 2026 | Microbiotica MB310 is an oral once-daily live biotherapeutic capsule containing eight sp... | £36,000,000 | |||||||||||
16 Oct 2026 | Medcotec The Helyx valve is a single-use, full-bore powder transfer valve for pharma... | £2,400,000 | |||||||||||
16 Oct 2026 | OMass Therapeutics OMS1620 is a small-molecule drug that binds the MC2 receptor to modify rece... | £233,750,000 US$310,000,000 | |||||||||||
14 Oct 2026 | HydRegen HydRegen provides a bio-based hydrogenation platform that formulates enzyme... | £6,040,000 US$8,000,000 | |||||||||||
14 Oct 2026 | Salience Labs Salience Labs makes an optical switch based on silicon photonics for datace... | £125,000,000 | |||||||||||
13 Oct 2026 | Undecimal Bio DELiveri is a platform that uses chemical screening and machine learning to... | £14,000,000 | |||||||||||
12 Oct 2026 | Sava Technologies Sava Technologies offers a wearable glucose microsensor that measures gluco... | £27,000,000 | |||||||||||
8 Oct 2026 | Neela Biotech A process using AI to guide microbial communities that convert organic wast... | £2,100,000 | |||||||||||
7 Oct 2026 | MintNeuro MintNeuro offers a modular semiconductor platform for neural devices that i... | £3,770,000 US$5,000,000 | |||||||||||
6 Oct 2026 | Sensible Biotechnologies A cell-based platform that produces naturally modified mRNA using engineere... | £35,550,000 US$47,000,000 | |||||||||||
29 Sept 2026 | 52North Neutrocheck is a rapid finger prick blood test that uses a biomarker detect... | £3,200,000 | |||||||||||
24 Sept 2026 | Basecamp Research Basecamp Research offers a drug discovery platform that combines genetic da... | £105,630,000 US$140,000,000 | |||||||||||
23 Sept 2026 | CSignum CSignum's EM2 is a hardware product family that uses electromagnetic signal... | £2,600,000 |

1 Explore 344 UK deeptech startups and their founders, who have collectively raised £11.80B.
2 Easily sort, filter, and compare the UK's top startups — customise the list to your needs.
3 Discover top startups for investment, B2B sales, partnerships, hiring, and industry connections.
You can connect with fast-growing deeptech startups with the full list of recently funded startups from the UK.
Deeptech startups are built on scientific and engineering breakthroughs rather than lightweight software alone. Across the UK, founders are turning advances in AI, robotics, quantum, semiconductors, materials and climate science into commercially scalable companies.
The UK has one of Europe's strongest deeptech ecosystems, supported by world-class universities, specialist research labs and a maturing investor base. London, Cambridge, Oxford, Bristol, Manchester and Edinburgh continue to produce high-growth deeptech companies across pre-seed to growth stages.
Deeptech in this context includes startups where defensible IP, advanced R&D and technical complexity drive long-term value creation. These companies often take longer to scale than traditional software startups, but can create category-defining outcomes with stronger barriers to entry.
Use this page to explore the fastest growing deeptech startups in the UK, then review company profiles for websites, investors, locations and recent funding rounds.
That is our view of the most active deeptech startups in the UK. If you are building in this category, finding investors who understand technical risk, longer R&D cycles and IP-led business models is critical.
Deeptech refers to technology companies built on significant scientific or engineering innovation. Unlike many software-first businesses, deeptech startups usually rely on proprietary research, complex product development and technical teams with domain expertise.
Key deeptech categories in the UK include:
Foundational technologies for model training, inference optimisation, AI hardware and enterprise deployment.
Intelligent machines and autonomous systems for logistics, manufacturing, defence, agriculture and healthcare.
Quantum hardware, software and enabling components for next-generation computing performance.
Breakthrough technologies in energy, carbon management, manufacturing efficiency and resource optimisation.
Novel materials, semiconductors and engineering platforms that unlock better performance across industries.
The UK's research depth and venture ecosystem make it a strong launchpad for deeptech founders building globally competitive companies.
Deeptech startups build companies around scientific, engineering or technical breakthroughs rather than simple software applications. UK deeptech startups often work across AI, robotics, quantum, biotech, semiconductors, advanced materials, space, climate technology and hardware.
The UK is strong in deeptech because of its universities, research institutions, technical talent, spinout activity and specialist investor base. Cambridge, Oxford, London, Bristol, Edinburgh, Manchester and Sheffield are important hubs for science-led and engineering-led startup creation.
Deeptech startups raise funding from angel investors, specialist venture capital firms, university spinout funds, grant programmes and strategic industry partners. They often need more patient capital than software startups because product development, validation and commercialisation can take longer.
Investors in deeptech startups look for defensible intellectual property, strong technical founders, evidence that the technology works and a large commercial market. They also assess whether the company can move from research to repeatable customers without becoming trapped in the lab.
Deeptech startups often take longer to commercialise because they must prove complex technology, build prototypes, protect intellectual property, navigate regulation or integrate with industrial customers. The upside can be significant, but execution risk is usually higher than in standard software startups.